What is Neuroleptic Malignant Syndrome and its primary features?

Study for the HESI Schizophrenia Case Study Test. Prepare with flashcards and multiple choice questions, each question provides hints and explanations. Get ready for your exam!

Multiple Choice

What is Neuroleptic Malignant Syndrome and its primary features?

Explanation:
Neuroleptic Malignant Syndrome is a rare but life-threatening reaction to antipsychotic medications or other dopamine-blocking drugs. It presents with a dangerous combination of hyperthermia, severe generalized rigidity (often described as lead-pipe rigidity), autonomic instability (such as fluctuating blood pressure and heart rate, sweating), and altered mental status. This constellation reflects intense central dopamine blockade and muscle breakdown, so recognizing it quickly is crucial. The immediate steps are to stop the offending drug and provide aggressive supportive care—cooling measures, IV fluids, careful electrolyte management, and close monitoring, typically in an ICU setting. In some situations, agents like dantrolene or bromocriptine may be used to assist recovery. Early identification and treatment significantly reduce the risk of serious complications like rhabdomyolysis, renal failure, and death. Other described options do not fit because they outline milder allergic reactions (rash and itching), common sedative side effects (drowsiness), or metabolic changes (weight gain), none of which capture the life-threatening, multisystem picture of Neuroleptic Malignant Syndrome.

Neuroleptic Malignant Syndrome is a rare but life-threatening reaction to antipsychotic medications or other dopamine-blocking drugs. It presents with a dangerous combination of hyperthermia, severe generalized rigidity (often described as lead-pipe rigidity), autonomic instability (such as fluctuating blood pressure and heart rate, sweating), and altered mental status. This constellation reflects intense central dopamine blockade and muscle breakdown, so recognizing it quickly is crucial. The immediate steps are to stop the offending drug and provide aggressive supportive care—cooling measures, IV fluids, careful electrolyte management, and close monitoring, typically in an ICU setting. In some situations, agents like dantrolene or bromocriptine may be used to assist recovery. Early identification and treatment significantly reduce the risk of serious complications like rhabdomyolysis, renal failure, and death.

Other described options do not fit because they outline milder allergic reactions (rash and itching), common sedative side effects (drowsiness), or metabolic changes (weight gain), none of which capture the life-threatening, multisystem picture of Neuroleptic Malignant Syndrome.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy